Skip header and navigation

14 records – page 1 of 2.

Document Type
Evidence Search Report
Review Code
EOC051201-01 ESR
Question Submitted
May 12, 2020
Date Completed
May 13, 2020
Status
3. Completed
Research Team
EOC
Document Type
Evidence Search Report
Review Code
EOC051201-01 ESR
Question Submitted
May 12, 2020
Date Completed
May 13, 2020
Status
3. Completed
Research Team
EOC
Category
Infection Prevention and Control
Clinical Management
Subject
Personal Protective Equipment
Aerosols
Priority Level
Level 3 completed within 2-3 days
Cite As
Dalidowicz, M; Miller, L. Do neck or back coverings provide additional protection to gown and N95 mask when conducting an aerosol generating procedure? 2020 May 13; Document no.: EOC051201-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 18 p. (CEST evidence search report)
Related Documents
Documents
Less detail
Document Type
Rapid Review
Review Code
EOC051201 RR
Question Submitted
May 12, 2020
Date Completed
May 15, 2020
Status
3. Completed
Research Team
EOC
Document Type
Rapid Review
Review Code
EOC051201 RR
Question Submitted
May 12, 2020
Date Completed
May 15, 2020
Status
3. Completed
Research Team
EOC
Key Findings
· Small simulation studies have demonstrated potential contamination of neck and back area · Many associations recommend neck coverage, or if unavailable to ensure sanitation/washing of exposed skin after doffing PPE · Several warnings that increasing amount of PPE increases chances of contamination and may decrease level of compliance
Category
Infection Prevention and Control
Clinical Management
Subject
Personal Protective Equipment
Aerosols
Priority Level
Level 3 completed within 2-3 days
Cite As
Badea, A; Groot, G; Dalidowicz, M; Miller, L. Do neck or back coverings provide additional protection to gown and N95 mask when conducting an aerosol generating procedure? 2020 May 15; Document no.: EOC051201 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 9 p. (CEST rapid review report)
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
EOC081401v2-01 ESR
Question Submitted
August 14, 2020
Date Completed
November 27, 2020
Status
5. Updated review
Research Team
EOC
for providers and patients due to the spread of aerosols. As a consequence, public health agencies
Document Type
Evidence Search Report
Review Code
EOC081401v2-01 ESR
Question Submitted
August 14, 2020
Date Completed
November 27, 2020
Status
5. Updated review
Research Team
EOC
Category
Administration
Infection Prevention and Control
Subject
Aerosols
Facilities
Decision Making
Priority Level
Level 4 completed within 1 week
Cite As
Miller, L. (Update) What are the recommendations around settling times following aerosol generating procedures on suspected or confirmed COVID-19 patients? 2020 Nov 27; Document no.: EOC081401v2-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 14 p. (CEST evidence search report)
Review History
EOC081401 RR: August 24, 2020
Related Documents
Documents

EOC081401v2-01 ESR

Read PDF Download PDF
Less detail
Document Type
Rapid Review
Review Code
EOC081401v2 RR
Question Submitted
August 14, 2020
Date Completed
December 1, 2020
Status
5. Updated review
Research Team
EOC
a table of times taken to clear the room of 99% or 99.9% of aerosols [3] and cites a 1994 document
Document Type
Rapid Review
Review Code
EOC081401v2 RR
Question Submitted
August 14, 2020
Date Completed
December 1, 2020
Status
5. Updated review
Research Team
EOC
Key Findings
In the absence of SARS-CoV-2 specific evidence, recommendations for fallow time following AGPs in the context of the SARS-CoV-2 pandemic range widely depending on country and specialty association.
The majority of recommendations are based upon dental practices and several on thoracic surgical practice.
The most common recommendations follow the CDC’s guidelines for airborne contamination removal based on air changes per hour ventilation properties of rooms.
Assuming that most treatment rooms have a minimum of 10-12 ACH, most associations recommend a 20-minute fallow periods, or 60 minutes if ACH is unknown or below recommendations for treatment rooms.
Category
Administration
Infection Prevention and Control
Subject
Aerosols
Facilities
Decision Making
Priority Level
Level 4 completed within 1 week
Cite As
Badea, A; Groot G; Dalidowicz, M; Young, C; Miller, L. What are the recommendations around settling times following aerosol generating procedures on suspected or confirmed COVID-19 patients? 2020 Dec 1; Document no.: EOC081401v2 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 24 p. (CEST rapid review report)
Review History
EOC081401 RR: August 24, 2020
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
EOC090202-01 ESR
Question Submitted
September 2, 2020
Date Completed
September 2, 2020
Status
3. Completed
Research Team
EOC
Successfully Prevents Exposure to Aerosols and Droplets during Transesophageal Echocardiography. New York
Document Type
Evidence Search Report
Review Code
EOC090202-01 ESR
Question Submitted
September 2, 2020
Date Completed
September 2, 2020
Status
3. Completed
Research Team
EOC
Category
Administration
Infection Prevention and Control
Subject
Intubation
Risk
Personal Protective Equipment
Aerosols
Transmission
Population
All
Priority Level
Level 3 completed within 2-3 days
Cite As
Ellsworth, C; Fox, L. What are the safety risks or disinfection concerns with the use of intubation boxes? 2020 Sep 2; Document no.: EOC090202-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 20 p. (CEST evidence search report)
Related Documents
Documents
Less detail
Document Type
Rapid Review
Review Code
EOC090202 RR
Question Submitted
September 2, 2020
Date Completed
September 8, 2020
Status
3. Completed
Research Team
EOC
to aerosols (1,6,8) and limitation for certain body habitus (obese, short neck patients) (6,12), have been
Document Type
Rapid Review
Review Code
EOC090202 RR
Question Submitted
September 2, 2020
Date Completed
September 8, 2020
Status
3. Completed
Research Team
EOC
Key Findings
· The Intubation box was originally invented by Dr. Lai Hsien-yung, an anesthesiologist in Taiwan. · The main function of the intubation box is intended to prevent exposure of care providers to COVID-19 from aerosol droplets during intubation. · The intubation box concept emerged during the pandemic to address the challenge of adequate supply of PPEs in resource limited settings in particular but presents limitations and poses significant safety risk to the patient. · limitations include increased incubation time, discomfort from restricted hand movements for the intubation procedure, reduced first-pass intubation rates, limitation for certain body habitus and possible injury to patient · With regards to aerosol exposure, intubation boxes have been reported to increase rather than decrease airborne particle exposure.
Category
Administration
Infection Prevention and Control
Subject
Intubation
Risk
Personal Protective Equipment
Aerosols
Transmission
Population
All
Priority Level
Level 3 completed within 2-3 days
Cite As
Asamoah, G; Groot, G; Badea, A; Ellsworth, C; Fox, L. What are the safety risks or disinfection concerns with the use of intubation boxes? 2020 Sep 8; Document no.: EOC090202 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 13 p. (CEST rapid review report)
Similar Reviews
EOC033001 RR
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
PPE041702-01 ESR
Question Submitted
April 17, 2020
Date Completed
April 17, 2020
Status
3. Completed
Research Team
Personal Protective Equipment
: Airborne transmission occurs only when infectious particles of <5 mum, known as aerosols, are propelled
Document Type
Evidence Search Report
Review Code
PPE041702-01 ESR
Question Submitted
April 17, 2020
Date Completed
April 17, 2020
Status
3. Completed
Research Team
Personal Protective Equipment
Notes
This was never assigned to an RR
Category
Clinical Management
Infection Prevention and Control
Subject
Aerosols
Personal Protective Equipment
Decision Making
Population
All
Priority Level
Level 2 completed within 8 hours
Cite As
Miller, L; Dalidowicz, M. What is the clinical evidence used to support aerosol generating medical procedures recommendations and guidelines regarding line flow volume or pressure? 2020 Apr 11; Document no.: PPE041702-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 12 p. (CEST evidence search report)
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
EOC040101-01 ESR
Question Submitted
April 1, 2020
Date Completed
April 1, 2020
Status
3. Completed
Research Team
EOC
procedures or support treatments that generate aerosols are performed; i.e., endotracheal intubation
Document Type
Evidence Search Report
Review Code
EOC040101-01 ESR
Question Submitted
April 1, 2020
Date Completed
April 1, 2020
Status
3. Completed
Research Team
EOC
Category
Epidemiology
Infection Prevention and Control
Subject
Aerosols
Risk
Transmission
Population
All
Clinical Setting
Ambulatory
Priority Level
Level 2 completed within 8 hours
Cite As
Dalidowicz, M; Young, C. What is the degree of COVID-19 transmission through the administration of nebulizer medication either in clinical practice or in animal experiments? 2020 Apr 1; Document no.: EOC040101-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 12 p. (CEST evidence search report)
Related Documents
Documents
Less detail
Document Type
Rapid Review
Review Code
EOC040101 RR
Question Submitted
April 1, 2020
Date Completed
April 1, 2020
Status
3. Completed
Research Team
EOC
administration to generate aerosols [SARS] - IPAC considers nebulization to be an aerosolizing procedure which
Document Type
Rapid Review
Review Code
EOC040101 RR
Question Submitted
April 1, 2020
Date Completed
April 1, 2020
Status
3. Completed
Research Team
EOC
Key Findings
· There are some recommendations and precautions from WHO, CDC, Canada and the UK that there is transmission of the COVID virus from the administration of nebulizer medication. · Some case studies of SARS found few instances that patients may likely be infected after aerosol generating procedures including nebulized medications, and although there are few evidences that demonstrates low risk of viral transmission from nebulizers, possibility of transmission remains
Category
Epidemiology
Infection Prevention and Control
Subject
Aerosols
Risk
Transmission
Population
All
Clinical Setting
Ambulatory
Priority Level
Level 2 completed within 8 hours
Cite As
Badea, A; Groot, G; Fenton, M; Dalidowicz, M; Young, C. What is the degree of COVID-19 transmission through the administration of nebulizer medication either in clinical practice or in animal experiments? 2020 Apr 1; Document no.: EOC040101 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 10 p. (CEST rapid review report)
Related Documents
Documents
Less detail
Document Type
Evidence Search Report
Review Code
EOC033101-01 ESR
Question Submitted
March 31, 2020
Date Completed
March 31, 2020
Status
3. Completed
Research Team
EOC
/876577/Infection_prevention_and_control_guidance_for_pandemic_coronavirus.pdf 2 Aerosols
Document Type
Evidence Search Report
Review Code
EOC033101-01 ESR
Question Submitted
March 31, 2020
Date Completed
March 31, 2020
Status
3. Completed
Research Team
EOC
Notes
No written rapid review
Category
Infection Prevention and Control
Subject
Aerosols
Surgical Procedures
Risk
Population
All
Clinical Setting
Medicine Unit
Priority Level
Level 2 completed within 8 hours
Cite As
Dalidowicz, M. What is the magnitude of risk of exposure to coronaviruses with intermediate and high risk upper GI endoscopy, ERCP and colonoscopy? 2020 Mar 31; Document no.: EOC033101-01 ESR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. 9 p. (CEST evidence search report)
Related Documents
Documents
Less detail

14 records – page 1 of 2.